至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Improved production of the recombinant phospholipase A1 from wasp venom expressed in bacterial cells for use in routine diagnostics

3 Biotech. 2020; 
Amilcar Perez-Riverol, Alexis Musacchio-Lasa, Luis Gustavo Romani Fernandes, Jose Roberto Aparecido Dos Santos-Pinto, Franciele Grego Esteves, Murilo Luiz Bazon, Ricardo de Lima Zollner, Mario Sergio Palma, Márcia Regina Brochetto-Braga
Products/Services Used Details Operation
Molecular Biology Reagents … The transformants were then selected using YPD-agar plates (1% yeast extract, 2% peptone, 2% dextrose, 2% agar) supplemented with 100 µg/mL of Zeocin (Invitrogen, CA, US). All of these procedures were con- ducted by Genscript (Piscataway, US) … Get A Quote

摘要

Phospholipase A1 (PLA1) is one of the three major allergens identified in the venom of (Hymenoptera: Vespidae), a clinically relevant wasp from southeastern Brazil. The recombinant form of this allergen (rPoly p 1) could be used for the development of molecular diagnostic of venom allergy. Early attempts to produce rPoly p 1 using BL21 (DE3) cells rendered high yields of the insoluble rPoly p 1 but with low levels of solubilized protein recovery (12%). Here, we aimed to improve the production of rPoly p 1 in by testing different conditions of expression, solubilization of the inclusion bodies and protein purification. The results showed that the expression at 16 °C and 0.1 mM of IPTG increased the producti... More

关键词

Molecular diagnostics, Polybia paulista, Recombinant phospholipase A1, Recovery, Solubilization, Venom allergy